Advertisement

Molecular Biology Reports

, Volume 40, Issue 10, pp 6035–6042 | Cite as

Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis

  • Fang-Fang Shen
  • Fu-You Zhou
  • Qi-Si Xue
  • Ying Pan
  • Lu Zheng
  • Hua Zhang
  • Li-Dong Wang
  • Hou-Feng Zheng
Article

Abstract

Cytochrome P4501A1 (CYP1A1) enzyme is a member of the CYP superfamily of enzymes. CYP1A1 A2455G and T3801C are two most commonly studied polymorphisms loci. Previous studies have reported that CYP1A1 polymorphisms increase esophageal cancer (EC) risk. However, the results remain controversial and ambiguous. To further investigate the association between CYP1A1 polymorphisms (A2455G and T3801C) and EC risk. A meta-analysis was performed to investigate the association between CYP1A1 polymorphisms and EC risk. A total of 13 articles (A2455G and T3801C: 2 papers, A2455G: 8 papers, T3801C: 3 papers) from the PubMed containing information on the CYP1A1 polymorphisms and EC were included in this meta-analysis, with summational sample size of 1,881 EC cases and 3,786 controls. Stratified analysis was performed to evaluate the ethnicity (Caucasians and Asian) and histopathology type (esophageal squamous cell carcinoma and esophageal adenocarcinoma) effect. No obvious publication bias in the two polymorphisms was observed. Our meta-analysis revealed a significant association between the A2455G polymorphism and EC (OR = 1.55 per A allele, 95 % CI 1.29–1.85, P < 0.001). Stratification analysis by ethnicity and histopathology type showed significant association in the population of Asian origin (OR = 1.55, 95 % CI 1.28–1.89, P < 0.001) and in histopathology type of ESCC (OR = 1.40, 95 % CI 1.19–1.65, P < 0.001). We didn’t observe the significant association between CYP1A1 T3801C polymorphism and EC. We observed a difference of allele frequencies between Caucasian and Asian population in the meta-analysis. The allele frequencies in our meta-analysis were consistent with the allele frequencies in 1000 Genome Project. Our meta-analysis demonstrated distinct evidence that CYP1A1 A2455G polymorphism was associated with the risk of EC.

Keywords

CYP1A1 Esophageal cancer Polymorphism Meta-analysis 

Notes

Acknowledgments

Dr. Hou-Feng Zheng is supported by the Canadian Institutes of Health Research (CIHR). We thank Dr. Wan-Cai Yang from the School of Basal Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China, for carefully reading of this manuscript.

Conflict of interest

None.

References

  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRefGoogle Scholar
  2. 2.
    Guo W, Jiang YG (2009) Current gene expression studies in esophageal carcinoma. Curr Genomics 10:534–539PubMedCrossRefGoogle Scholar
  3. 3.
    Daly JM, Fry WA, Little AG, Winchester DP, McKee RF, Stewart AK et al (2000) Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 190:562–572 discussion 563–572PubMedCrossRefGoogle Scholar
  4. 4.
    Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL et al (2003) Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404–1413PubMedCrossRefGoogle Scholar
  5. 5.
    Morita M, Kumashiro R, Kubo N, Nakashima Y, Yoshida R, Yoshinaga K et al (2010) Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol 15:126–134PubMedCrossRefGoogle Scholar
  6. 6.
    Messmann H (2001) Squamous cell cancer of the oesophagus. Best Pract Res Clin Gastroenterol 15:249–265PubMedCrossRefGoogle Scholar
  7. 7.
    Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW et al (2005) Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 113:456–463PubMedCrossRefGoogle Scholar
  8. 8.
    Hongo M, Nagasaki Y, Shoji T (2009) Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24:729–735PubMedCrossRefGoogle Scholar
  9. 9.
    Cheung WY, Liu G (2009) Genetic variations in esophageal cancer risk and prognosis. Gastroenterol Clin North Am 38:75–91PubMedCrossRefGoogle Scholar
  10. 10.
    Agundez JA (2004) Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 5:211–224PubMedCrossRefGoogle Scholar
  11. 11.
    Cascorbi I, Brockmoller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56:4965–4969PubMedGoogle Scholar
  12. 12.
    Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 110:407–411PubMedGoogle Scholar
  13. 13.
    Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263:131–133PubMedCrossRefGoogle Scholar
  14. 14.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560PubMedCrossRefGoogle Scholar
  15. 15.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMedCrossRefGoogle Scholar
  16. 16.
    Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRefGoogle Scholar
  17. 17.
    Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B (2010) Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer 62:734–742PubMedCrossRefGoogle Scholar
  18. 18.
    Jain M, Kumar S, Ghoshal UC, Mittal B (2007) CYP1A1 Msp1 T/C polymorphism in esophageal cancer: no association and risk modulation. Oncol Res 16:437–443PubMedGoogle Scholar
  19. 19.
    Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR et al (2003) Associations between genetic polymorphisms of phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 27:139–146PubMedCrossRefGoogle Scholar
  20. 20.
    van Lieshout EM, Roelofs HM, Dekker S, Mulder CJ, Wobbes T, Jansen JB et al (1999) Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett’s esophagus and esophageal carcinoma. Cancer Res 59:586–589PubMedGoogle Scholar
  21. 21.
    Hori H, Kawano T, Endo M, Yuasa Y (1997) Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. J Clin Gastroenterol 25:568–575PubMedCrossRefGoogle Scholar
  22. 22.
    Wang D, Su M, Tian D, Liang S, Zhang J (2012) Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China. Cancer Epidemiol 36:276–282PubMedCrossRefGoogle Scholar
  23. 23.
    Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL et al (2007) GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev 31:233–236PubMedCrossRefGoogle Scholar
  24. 24.
    Abbas A, Delvinquiere K, Lechevrel M, Lebailly P, Gauduchon P, Launoy G et al (2004) GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol 10:3389–3393PubMedGoogle Scholar
  25. 25.
    Wang AH, Sun CS, Li LS, Huang JY, Chen QS (2002) Relationship of tobacco smoking CYP1A1 GSTM1 gene polymorphism and esophageal cancer in Xi’an. World J Gastroenterol 8:49–53PubMedGoogle Scholar
  26. 26.
    Shao G, Su Y, Huang G, Wen B (2000) Relationship between CYP1A1, GSTM1 genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi 21:420–423PubMedGoogle Scholar
  27. 27.
    Zhang H, Sun C, Li L, Yan M (2000) Cytochrome P450IA1 and the genetic susceptibility to esophageal carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi 34:69–71PubMedGoogle Scholar
  28. 28.
    Morita S, Yano M, Shiozaki H, Tsujinaka T, Ebisui C, Morimoto T et al (1997) CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 71:192–195PubMedCrossRefGoogle Scholar
  29. 29.
    Nimura Y, Yokoyama S, Fujimori M, Aoki T, Adachi W, Nasu T et al (1997) Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer 80:852–857PubMedCrossRefGoogle Scholar
  30. 30.
    Wang AH, Sun CS, Li LS, Huang JY, Chen QS, Xu DZ (2004) Genetic susceptibility and environmental factors of esophageal cancer in Xi’an. World J Gastroenterol 10:940–944PubMedGoogle Scholar
  31. 31.
    Wang Z, Tang L, Sun G, Tang Y, Xie Y, Wang S et al (2006) Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer 6:287PubMedCrossRefGoogle Scholar
  32. 32.
    Sepehr A, Kamangar F, Abnet CC, Fahimi S, Pourshams A, Poustchi H et al (2004) Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. Cancer Lett 213:195–202PubMedCrossRefGoogle Scholar
  33. 33.
    Layke JC, Lopez PP (2006) Esophageal cancer: a review and update. Am Fam Phys 73:2187–2194Google Scholar
  34. 34.
    Wu C, Kraft P, Zhai K, Chang J, Wang Z, Li Y et al (2012) Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet 44:1090–1097PubMedCrossRefGoogle Scholar
  35. 35.
    Umar SB, Fleischer DE (2008) Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 5:517–526 Google Scholar
  36. 36.
    Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y et al (2011) Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet 43:679–684PubMedCrossRefGoogle Scholar
  37. 37.
    Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y et al (2010) Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 42:759–763PubMedCrossRefGoogle Scholar
  38. 38.
    Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO et al (2010) A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 42:764–767PubMedCrossRefGoogle Scholar
  39. 39.
    Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3–28PubMedGoogle Scholar
  40. 40.
    Lechevrel M, Casson AG, Wolf CR, Hardie LJ, Flinterman MB, Montesano R et al (1999) Characterization of cytochrome P450 expression in human oesophageal mucosa. Carcinogenesis 20:243–248PubMedCrossRefGoogle Scholar
  41. 41.
    Chen C, Huang Y, Li Y, Mao Y, Xie Y (2007) Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk: a meta-analysis. J Hum Genet 52:423–435PubMedCrossRefGoogle Scholar
  42. 42.
    Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ et al (1994) Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4:242–246PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Fang-Fang Shen
    • 1
  • Fu-You Zhou
    • 2
  • Qi-Si Xue
    • 3
  • Ying Pan
    • 1
  • Lu Zheng
    • 4
  • Hua Zhang
    • 1
  • Li-Dong Wang
    • 5
  • Hou-Feng Zheng
    • 6
    • 7
  1. 1.The Key Laboratory for Tumor Translational Medicine, The Third Affiliated HospitalXinxiang Medical UniversityXinxiangChina
  2. 2.Department of Thoracic SurgeryAnyang Tumor HospitalAnyangChina
  3. 3.Intensive Care UnitRoyal Victoria HospitalMontrealCanada
  4. 4.Fuzhou Medical CollegeNanchang UniversityNanchangChina
  5. 5.Henan Key Laboratory for Esophageal Cancer Research, The First Affiliated HospitalZhengzhou UniversityZhengzhouChina
  6. 6.Department of Medicine and Human GeneticsMcGill UniversityMontrealCanada
  7. 7.Department of Epidemiology and BiostatisticsLady Davis Institute, Jewish General HospitalMontrealCanada

Personalised recommendations